John G. Aunins Ph.D. — Chief Technology Officer and Executive Vice President of Bioprocess & Manufacturing at Seres Therapeutics | Comparably
Seres Therapeutics Claimed Company
Seres Health researches and develops ecobiotic therapeutic products. read more
EMPLOYEE
PARTICIPANTS
9
TOTAL
RATINGS
108
HR or Marketing? Claim Your Free Employer Account
John G. Aunins Ph.D. — Chief Technology Officer and Executive Vice President of Bioprocess & Manufacturing at Seres Therapeutics

John G. Aunins Ph.D. — Chief Technology Officer and Executive Vice President of Bioprocess & Manufacturing at Seres Therapeutics

Executive Bio

Dr. John G. Aunins, Ph.D. has been the Chief Technology Officer and Executive Vice President of Bioprocess & Manufacturing at Seres Therapeutics, Inc. since December 2012. Dr. Aunins serves as an Executive Vice President of CMC at Seres Health, Inc. Dr. Aunins served as Vice President of process development at Merck Inc. He is a 24-year veteran in the biotech field, with deep experience in bioprocess development, manufacturing support and project leadership. He led process and product development teams at Merck Research Laboratories for Vaqta???, Varivax???, Zostavax???, ProQuad???, Rotateq???, and Gardasil???. The Vaqta and Gardasil process teams were awarded with ACS Industrial Biotechnology Awards for innovation, contribution to bioengineering and societal impact. Dr. Aunins has been a Member of Technology Advisory Board at Moderna Therapeutics, Inc. since May 21, 2014. He is a Fellow of the American Institute for Medical and Biological Engineering and an adjunct Full Professor at the Instituto de Tecnologia Quimica e Biologica (ITQB) in Oeiras, Portugal. He is author of over 50 articles and book chapters and has chaired five international conferences in vaccines and bioprocess technology. Dr. Aunins holds a Ph.D. in Chemical Engineering from M.I.T.. Dr. Aunins received his B.S. from the University of Kansas.

Chief Technology Officer and Executive Vice President of Bioprocess & Manufacturing Impact on Engineering Department's Culture

John G. Aunins Ph.D. holds the highest position within the Engineering department at Seres Therapeutics — Chief Technology Officer and Executive Vice President of Bioprocess & Manufacturing, and therefore has influence on the culture of the Engineering department.

AnswerPercent
YesNaN%
NoNaN%
Are you challenged at work?
AnswerPercent
YesNaN%
NoNaN%
Are your company's goals clear, and are you invested in them?
AnswerPercent
YesNaN%
NoNaN%
Are you satisfied with your work/life balance?
AnswerPercent
Positive0%
Negative0%
Is your work environment positive or negative?
AnswerPercent
Great0%
Good0%
Average0%
Poor0%
Horrible0%
How would you rate the value & quality of meetings at your company?
AnswerPercent
YesNaN%
NoNaN%
Does your current company provide you meaningful opportunities for career advancement?

Executive Team Culture Ratings from Seres Therapeutics Employees

TOP
50%
Seres Therapeutics' Executive Team scores in the Top 50%
of similar sized companies on Comparably
Who ranks the Executive Team the highest?
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Seres Therapeutics
Who ranks the Executive Team the lowest?
Not Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Seres Therapeutics

Seres Therapeutics' Executive Team at a Glance

Based on 5 ratings, Seres Therapeutics' employees are less satisfied with their Executive Team and give them a ā€œC+ā€ or 66/100.

Seres Therapeutics' Executive Team ranks in the Bottom 40% of other companies in Boston and Top 50% of other companies on Comparably that also have 201-500 Employees.

×
Rate your company